An ocular view of the IGF–IGFBP system

Ferry, 1999, Insulin-like growth factor binding proteins: new proteins, new functions, Horm. Res., 51, 53, 10.1159/000023315 Baxter, 1989, Binding proteins for the insulin-like growth factors: structure, regulation and function, Prog. Growth Factor Res., 1, 49, 10.1016/0955-2235(89)90041-0 Chang, 2007, IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development, Proc. Natl. Acad. Sci. U. S. A., 104, 10595, 10.1073/pnas.0702072104 Shimasaki, 1991, Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6), Prog. Growth Factor Res., 3, 243, 10.1016/0955-2235(91)90003-M Rechler, 1993, Insulin-like growth factor binding proteins, Vitam. Horm., 47, 1, 10.1016/S0083-6729(08)60444-6 Jones, 1995, Insulin-like growth factors and their binding proteins: biological actions, Endocr. Rev., 16, 3 Rosenfeld, 1990, Insulinlike growth factor-binding proteins, Recent Prog. Horm. Res., 46, 99 Zapf, 1995, Physiological role of the insulin-like growth factor binding proteins, Eur. J. Endocrinol., 132, 645, 10.1530/eje.0.1320645 Lamson, 1991, Insulin-like growth factor binding proteins: structural and molecular relationships, Growth Factors, 5, 19, 10.3109/08977199109000268 Rodgers, 2008, Phylogenetic analysis of the insulin-like growth factor binding protein (IGFBP) and IGFBP-related protein gene families, Gen. Comp. Endocrinol., 155, 201, 10.1016/j.ygcen.2007.04.013 Ruan, 2010, Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?, Acta Diabetol., 47, 5, 10.1007/s00592-009-0142-3 Firth, 2002, Cellular actions of the insulin-like growth factor binding proteins, Endocr. Rev., 23, 824, 10.1210/er.2001-0033 Higashi, 2012, Aging, atherosclerosis, and IGF-1, J. Gerontol. A Biol. Sci. Med. Sci., 67, 626, 10.1093/gerona/gls102 Grant, 1986, Changes in insulin-like growth factors I and II and their binding protein after a single intramuscular injection of growth hormone, J. Clin. Endocrinol. Metab., 63, 981, 10.1210/jcem-63-4-981 Schultz, 1991, Neovascular growth factors, Eye (Lond.), 5, 170, 10.1038/eye.1991.31 Gluckman, 1995, Clinical review 68: the endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factors, J. Clin. Endocrinol. Metab., 80, 1047, 10.1210/jc.80.4.1047 Löfqvist, 2009, A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants, Pediatr. Res., 65, 574, 10.1203/PDR.0b013e31819d9e8c Hellström, 2003, Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth, Pediatrics, 112, 1016, 10.1542/peds.112.5.1016 Cobb, 2004, Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function, J. Cell Sci., 117, 1737, 10.1242/jcs.01028 Salih, 2004, Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice, Proc. Natl. Acad. Sci. U. S. A., 101, 4314, 10.1073/pnas.0400230101 Samuel, 2010, Decreased expression of insulin-like growth factor binding protein-5 during N-(4-hydroxyphenyl)retinamide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells: regulation by CCAAT/enhancer-binding protein, J. Cell. Physiol., 224, 827, 10.1002/jcp.22191 Delafontaine, 2004, Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels, Arterioscler. Thromb. Vasc. Biol., 24, 435, 10.1161/01.ATV.0000105902.89459.09 Shai, 2010, Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe−/− mice does not alter atherosclerotic plaque burden but increases features of plaque stability, Arterioscler. Thromb. Vasc. Biol., 30, 1916, 10.1161/ATVBAHA.110.210831 Libby, 2006, Plaque stabilization: can we turn theory into evidence?, Am. J. Cardiol., 98, 26P, 10.1016/j.amjcard.2006.09.017 Shai, 2011, Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice, Am. J. Physiol. Heart Circ. Physiol., 300, H1898, 10.1152/ajpheart.01081.2010 Rajwani, 2012, Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis, Diabetes, 61, 915, 10.2337/db11-0963 Wang, 2012, The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation, Atherosclerosis, 220, 102, 10.1016/j.atherosclerosis.2011.10.032 Rajah, 1997, Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism, J. Biol. Chem., 272, 12181, 10.1074/jbc.272.18.12181 Harms, 2005, The C terminus of p53 family proteins is a cell fate determinant, Mol. Cell. Biol., 25, 2014, 10.1128/MCB.25.5.2014-2030.2005 Lee, 2005, Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77, J. Biol. Chem., 280, 16942, 10.1074/jbc.M412757200 Mehta, 2011, IGFBP-3 is a metastasis suppression gene in prostate cancer, Cancer Res., 71, 5154, 10.1158/0008-5472.CAN-10-4513 Liu, 2007, Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis, Oncogene, 26, 1811, 10.1038/sj.onc.1209977 Grkovic, 2012, IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments, Oncogene, 1 Ingermann, 2010, Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer, J. Biol. Chem., 285, 30233, 10.1074/jbc.M110.122226 D'Ercole, 1984, Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action, Proc. Natl. Acad. Sci. U. S. A., 81, 935, 10.1073/pnas.81.3.935 King, 1985, Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta, J. Clin. Invest., 75, 1028, 10.1172/JCI111764 Grant, 1987, Insulin-like growth factor-I modulates endothelial cell chemotaxis, J. Clin. Endocrinol. Metab., 65, 370, 10.1210/jcem-65-2-370 Grant, 1986, Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization, Diabetes, 35, 416, 10.2337/diabetes.35.4.416 Walker, 2002, Role for alpha 6 integrin during lens development: evidence for signaling through IGF-1R and ERK, Dev. Dyn., 223, 273, 10.1002/dvdy.10050 Rosenthal, 2004, Insulin-like growth factor-1 contributes to neovascularization in age-related macular degeneration, Biochem. Biophys. Res. Commun., 323, 1203, 10.1016/j.bbrc.2004.08.219 Zygar, 2005, IGF-1 produced by cone photoreceptors regulates rod progenitor proliferation in the teleost retina, Brain Res. Dev. Brain Res., 154, 91, 10.1016/j.devbrainres.2004.10.009 Li, 1999, Basic FGF-induced down-regulation of IGF-I mRNA in cultured rat Müller cells, Exp. Eye Res., 68, 19, 10.1006/exer.1998.0572 Shaw, 2006, Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization, Gene Ther., 13, 752, 10.1038/sj.gt.3302718 Ishikawa, 2010, Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy, Investig. Ophthalmol. Vis. Sci., 51, 4307, 10.1167/iovs.09-4605 Lofqvist, 2009, Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice, Investig. Ophthalmol. Vis. Sci., 50, 1831, 10.1167/iovs.08-2903 Kondo, 2003, Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization, J. Clin. Invest., 111, 1835, 10.1172/JCI200317455 Guidry, 2011, Isolation and characterization of vitreous insulin-like growth factor binding proteins, Investig. Ophthalmol. Vis. Sci., 52, 303, 10.1167/iovs.10-5920 Schoen, 1995, Identification and partial characterization of a proteinase specific for insulin-like growth factor binding protein-3 in aqueous and vitreous humors, Curr. Eye Res., 14, 127, 10.3109/02713689508999924 Bergman, 2005, Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye, Investig. Ophthalmol. Vis. Sci., 46, 2708, 10.1167/iovs.04-0921 Mullins, 1990, Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene, Nature, 344, 541, 10.1038/344541a0 Meyer-Schwickerath, 1993, Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects, J. Clin. Invest., 92, 2620, 10.1172/JCI116877 Spranger, 2000, Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy, Horm. Metab. Res., 32, 196, 10.1055/s-2007-978621 Spranger, 2001, Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?, Horm. Metab. Res., 33, 312, 10.1055/s-2001-15283 Kielczewski, 2009, Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation, Circ. Res., 105, 897, 10.1161/CIRCRESAHA.109.199059 Segal, 2006, Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes, Diabetes, 55, 102, 10.2337/diabetes.55.01.06.db05-0803 Li Calzi, 2008, Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes, Diabetes, 57, 2488, 10.2337/db08-0381 Lofqvist, 2007, IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth, Proc. Natl. Acad. Sci. U. S. A., 104, 10589, 10.1073/pnas.0702031104 Kielczewski, 2011, Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury, Am. J. Pathol., 178, 1517, 10.1016/j.ajpath.2010.12.031 Davies, 2006, Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina, Mol. Vis., 12, 467 Lee, 2011, Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases, J. Biol. Chem., 286, 17898, 10.1074/jbc.M111.231035 Jeschke, 2000, Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children, Ann. Surg., 231, 246, 10.1097/00000658-200002000-00014 Spies, 2002, Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children, Crit. Care Med., 30, 83, 10.1097/00003246-200201000-00013 Jarajapu, 2012, Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3, PLoS One, 7, e39398, 10.1371/journal.pone.0039398 Zhang, 2008, Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas, Diabetes, 57, 1026, 10.2337/db07-0982 Kielczewski, 2011, Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase), Investig. Ophthalmol. Vis. Sci., 52, 8278, 10.1167/iovs.11-8167 Miller, 2007, Regulation of igf-I signaling in retinal endothelial cells by hyperglycemia, Investig. Ophthalmol. Vis. Sci., 48, 3878, 10.1167/iovs.07-0014 Yuhanna, 2001, High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase, Nat. Med., 7, 853, 10.1038/89986 Trigatti, 2000, The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism, Curr. Opin. Lipidol., 11, 123, 10.1097/00041433-200004000-00004 Nofer, 2004, HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3, J. Clin. Invest., 113, 569, 10.1172/JCI200418004 Wilson, 2001, Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy, Growth Horm. IGF Res., 11, S53, 10.1016/S1096-6374(01)80009-5 Ning, 2008, Expression of integrins in human proliferative diabetic retinopathy membranes, Can. J. Ophthalmol., 43, 683, 10.3129/i08-145 Spoerri, 2003, Expression of IGFBP-3 by human retinal endothelial cell cultures: IGFBP-3 involvement in growth inhibition and apoptosis, Investig. Ophthalmol. Vis. Sci., 44, 365, 10.1167/iovs.02-0309 Yoo, 2011, Insulin-like growth factor-binding protein-3 mediates high glucose-induced apoptosis by increasing oxidative stress in proximal tubular epithelial cells, Endocrinology, 152, 3135, 10.1210/en.2010-1122 Crawford, 2009, Diabetic retinopathy and angiogenesis, Curr. Diabetes Rev., 5, 8, 10.2174/157339909787314149 Rho, 2008, Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis, Carcinogenesis, 29, 2106, 10.1093/carcin/bgn206 Contois, 2012, Insulin-like growth factor binding protein-4 differentially inhibits growth factor-induced angiogenesis, J. Biol. Chem., 287, 1779, 10.1074/jbc.M111.267732 Prêle, 2012, Insulin-like growth factor-1 overexpression in cardiomyocytes diminishes ex vivo heart functional recovery after acute ischemia, Cardiovasc. Pathol., 21, 17, 10.1016/j.carpath.2010.11.008 Panjala, 2010, Effects of insulin-like growth factor-1 (IGF-1) receptor signaling on rates of apoptosis in retina of dopamine beta hydroxylase (Dbh−/−) knockout mice, Auton. Neurosci., 152, 21, 10.1016/j.autneu.2009.08.014 Wu, 2012, Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium, Ocul. Surf., 10, 100, 10.1016/j.jtos.2012.01.004 Merimee, 1983, Insulin-like growth factors. Studies in diabetics with and without retinopathy, N. Engl. J. Med., 309, 527, 10.1056/NEJM198309013090904 Dills, 1991, Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes, Diabetes, 40, 1725, 10.2337/diabetes.40.12.1725 Hyer, 1989, A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy, Metab. Clin. Exp., 38, 586, 10.1016/0026-0495(89)90222-9 Chantelau, 1997, Elevation of serum IGF-1 precedes proliferative diabetic retinopathy in Mauriac's syndrome, Br. J. Ophthalmol., 81, 169, 10.1136/bjo.81.2.168b Feldmann, 2000, Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins, Growth Horm. IGF Res., 10, 53, 10.1054/ghir.2000.0140 Frystyk, 2003, The relationship between the circulating IGF system and the presence of retinopathy in type 1 diabetic patients, Diabet. Med., 20, 269, 10.1046/j.1464-5491.2003.00921.x Fujihara, 1996, Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication, Clin. Nephrol., 45, 372 Wedrychowicz, 2005, Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria, Horm. Res., 63, 245, 10.1159/000085941 Bereket, 1999, Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus, Horm. Metab. Res., 31, 172, 10.1055/s-2007-978716 Chiarelli, 2004, Growth, growth factors and diabetes, Eur. J. Endocrinol., 151, U109, 10.1530/eje.0.151U109 Feldmann, 1999, Decreased serum level of free bioavailable IGF-I in patients with diabetic retinopathy, Ophthalmologe, 96, 300, 10.1007/s003470050409 Capoluongo, 2006, Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes, Cytokine, 34, 303, 10.1016/j.cyto.2006.06.007 Payne, 2011, Serum insulin-like growth factor-I in diabetic retinopathy, Mol. Vis., 17, 2318 Pastor, 1998, Major review proliferative vitreoretinopathy: an overview, 43 Charteris, 2002, Proliferative vitreoretinopathy—developments in adjunctive treatment and retinal pathology, Eye (Lond.), 16, 369, 10.1038/sj.eye.6700194 Pastor, 2002, Proliferative vitreoretinopathy: risk factors and pathobiology, Prog. Retin. Eye Res., 21, 127, 10.1016/S1350-9462(01)00023-4 Grierson, 1996, Non-vascular vitreoretinopathy: the cells and the cellular basis of contraction, Eye (Lond.), 10, 671, 10.1038/eye.1996.160 Peters, 1986, Development of traction retinal detachments following intravitreal injections of retinal Muller and pigment epithelial cells, Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 224, 554, 10.1007/BF02154745 Yang, 1996, Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom, Investig. Ophthalmol. Vis. Sci., 37, 843 Wong, 2002, Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells, Can. J. Ophthalmol., 37, 211, 10.1016/S0008-4182(02)80112-0 Khaliq, 1996, Oxygen modulates the response of the retinal pigment epithelium to basic fibroblast growth factor and epidermal growth factor by receptor regulation, Investig. Ophthalmol. Vis. Sci., 37, 436 Hiscott, 1999, Matrix and the retinal pigment epithelium in proliferative retinal disease, Prog. Retin. Eye Res., 18, 167, 10.1016/S1350-9462(98)00024-X Mukherjee, 2009, Phenotype-associated changes in retinal pigment epithelial cell expression of insulin-like growth factor binding proteins, Investig. Ophthalmol. Vis. Sci., 50, 5449, 10.1167/iovs.09-3383 Mukherjee, 2007, The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation, Investig. Ophthalmol. Vis. Sci., 48, 1892, 10.1167/iovs.06-1095 Sureshbabu, 2009, IGFBP-5 induces epithelial and fibroblast responses consistent with the fibrotic response, Biochem. Soc. Trans., 37, 882, 10.1042/BST0370882 Yasuoka, 2009, The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration, Am. J. Respir. Cell Mol. Biol., 41, 179, 10.1165/rcmb.2008-0211OC Moysidis, 2012, Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside, Mediat. Inflamm., 2012, 815937, 10.1155/2012/815937 Klein, 1994, Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population, Arch. Ophthalmol., 112, 92, 10.1001/archopht.1994.01090130102026 Katsi, 2012, Impact of arterial hypertension on the eye, Curr. Hypertens. Rep., 14, 581, 10.1007/s11906-012-0283-6 Wong, 2003, Retinal vessel diameters and their associations with age and blood pressure, Investig. Ophthalmol. Vis. Sci., 44, 4644, 10.1167/iovs.03-0079 Sowers, 1997, Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology, Hypertension, 29, 691, 10.1161/01.HYP.29.3.691 Zhang, 2011, Plasma insulin-like growth factor-1 level and risk of incident hypertension in nondiabetic women, J. Hypertens., 29, 229, 10.1097/HJH.0b013e32834103bf Sharrett, 1999, Retinal arteriolar diameters and elevated blood pressure: the atherosclerosis risk in communities study, Am. J. Epidemiol., 150, 263, 10.1093/oxfordjournals.aje.a009997 Wong, 2002, Retinal microvascular abnormalities and blood pressure in older people: the cardiovascular health study, Br. J. Ophthalmol., 86, 1007, 10.1136/bjo.86.9.1007 Landi, 2005, The ilSIRENTE study: a prospective cohort study on persons aged 80years and older living in a mountain community of Central Italy, Aging Clin. Exp. Res., 17, 486, 10.1007/BF03327416 Onder, 2007, Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study, Eur. J. Clin. Pharmacol., 63, 389, 10.1007/s00228-007-0262-z Rabb, 1988, Retinal arterial macroaneurysms, Surv. Ophthalmol., 33, 73, 10.1016/0039-6257(88)90160-9 DellaCroce, 2008, Hypertension and the eye, Curr. Opin. Ophthalmol., 19, 493, 10.1097/ICU.0b013e3283129779 Abu-Safieh, 2011, Mutation of IGFBP7 causes upregulation of BRAF/MEK/ERK pathway and familial retinal arterial macroaneurysms, Am. J. Hum. Genet., 89, 313, 10.1016/j.ajhg.2011.07.010 López-Bermejo, 2007, Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/MAC25) is linked to endothelial-dependent vasodilation in high-ferritin type 2 diabetes, Diabetes Care, 30, 1615, 10.2337/dc06-1905